Cayuse is the market leader in research administrative software. It offers scalable solutions that empower organisations to conduct globally connected research and sponsored projects. Its industry-leading software modernises processes, improves collaboration, reduces compliance risks, saves time and increases transparency across all points of the research lifecycle.
Macquarie Capital acted as the exclusive sell-side advisor to Cayuse LLC on its majority investment by Primus Capital. It ran a competitive process, marketing the business on forward revenue and navigating uncertain market conditions to garner significant interest from both financial sponsors and strategics within the research, education and healthcare sectors. Leveraging a large network, it engaged Primus Capital a private equity firm focused on investing in leading technology-oriented growth companies.
The investment comes at a time of continued growth by Cayuse, driven by the company's focus on product innovation and the resilience of institutional research.
Matt McLellan, CEO, Cayuse
The growth capital provided by Primus will allow Cayuse to further accelerate organic and inorganic growth, expedite its vision to enable globally connected research and continue to be the leading provider of connected research to a range of academic institutions, healthcare providers and government agencies across the US.
The investment also ensures continuity of service for Cayuse’s 350 customers and the continued innovation that will reduce administrative burden and advance their organizations impact on science, discovery and society.
research institutions, universities, and hospitals served
employees focused on serving research organisations
to increase innovation and service provisions
Sam Shah, Global Head of Services, Macquarie Capital